同: IMP

同: IMP

WordNet

a nucleoside that is formed by the deamination of adenosine; used in kidney transplantation to provide a temporary source of sugar

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2014/09/18 17:56:18」(JST)

wiki en

Inosinic acid or inosine monophosphate (IMP) is a nucleoside monophosphate. Inosinic acid is important in metabolism. It is the ribonucleotide of hypoxanthine and the first nucleotide formed during the synthesis of purine. It is formed by the deamination of adenosine monophosphate, and is hydrolysed from inosine. IMP is an intermediate ribonucleoside monophosphate in purine metabolism. The enzyme deoxyribonucleoside triphosphate pyrophosphohydrolase, encoded by YJR069C in S. cerevisiae and containing (d)ITPase and (d)XTPase activities, hydrolyses ITP releasing pyrophosphate and IMP.^[1]

Important derivatives of inosinic acid include purine nucleotides found in nucleic acids and adenosine triphosphate, which is used to store chemical energy in muscle and other tissues.

In the food industry, inosinic acid and its salts such as disodium inosinate are used as flavour enhancers.

Inosinate synthesis

The inosinate synthesis is complex, beginning with a 5-phosphoribosyl-1-pyrophosphate (PRPP). In the first step, an amino group given by glutamine is attached at carbon 1 of PRPP. The resulting molecule is 5-phosphoribosylamine, which is highly unstable, with a half-life of 30 seconds at physiologic pH. 5-Phosphoribosylamine gains an amino acid (glycine), becoming glycinamide ribonucleotide (GAR). Then, N10-formyltetrahydrofolate (Tetrahydrofolate) transfers a formyl group to glycinamide ribonucleotide to form formyl glycinamide ribonucleotide (FGAR).

This figure shows the pathway described: IMP synthesis.

Using an ATP molecule, glutamine donates an ammonia^{[dubious – discuss]} molecule which is added to the compound forming formylglycinamidine ribonucleotide. Another ATP molecule causes an intermolecular reaction that produces an imidazole ring (5-aminoimidazole ribonucleotide).

The next step of the pathway is adding bicarbonate to make carboxyaminoimidazole ribonucleotide by using ATP (it only happens in fungi and bacteria; high eukaryotes simply add CO2 to form the ribonucleotide). Then, the imidazole’s carboxylate group phosphatises and adds aspartate.

As we have just seen, a six-step process links glycine, formate, bicarbonate, glutamine, and aspartate to lead to an intermediate that contains almost all the required atoms to synthesize a purine ring. This intermediate removes fumarate, and a second formyl group from THF is added. The compound gets cycled and forms inosinate^{[dubious – discuss]} after a sort of intermolecular reactions. Inosinate is the first intermediate in this synthesis pathway to have a whole purine ring.

Enzymes taking part in IMP synthesis constitute a multienzyme complex in the cell. Evidences demonstrate that there are multifunctional enzymes, and some of them catalyze non-sequential steps in the pathway.

Adenylate (AMP) and guanylate (GMP) come from inosinate

Within a few steps inosinate becomes AMP or GMP. Both compounds are RNA nucleotides. AMP differs from inosinate by the replacement of IMP's carbon-6 carbonyl with an amino group. The interconversion of AMP and IMP occurs as part of the purine nucleotide cycle.^[2] GMP is formed by the inosinate oxidation to xanthylate (XMP), and afterwards adds an amino group on carbon 2. Hydrogen acceptor on inosinate oxidation is NAD+. Finally, carbon 2 gains the amino group by spending an ATP molecule (which becomes AMP+2Pi). While AMP synthesis requires GTP, GMP synthesis uses ATP. That difference offers an important regulation possibility.

Glutamine-PRPP-amidotransferase

Inosinate takes part in the regulation of purine nucleotides biosynthesis

Inosinate and many other molecules inhibit the synthesis of 5-phosphorybosilamine from 5-phosphoribosyl-1-pyrophosphate (PRPP), disabling the enzyme that catalyzes the reaction: glutamine-5-phosphoribosyl-1-pyrophosphate-amidotransferase. In other words, when levels of inosinate are high, glutamine-5-phosphoribosyl-1-pyrophosphate-amidotransferase is inhibited, and, as a consequence, inosinate levels decrease. Also, as a result, adenylate and guanylate are not produced, which means that RNA synthesis cannot be completed because of the lack of these two important RNA nucleotides.

Applications

Inosinate can be manufactured into various compounds with the aid of genetically modified organisms:^{[citation needed]} disodium inosinate E 631, dipotassium inosinate E 632, and dicalcium inosinate E 633. These three compounds are used as flavour enhancers with a comparatively high effectiveness. They are mostly used in soups, sauces, and seasonings for the intensification and balance of meat taste.

References

^ Davies O, Mendes P, Smallbone K, Malys N (2012). "Characterisation of multiple substrate-specific (d)ITP/(d)XTPase and modelling of deaminated purine nucleotide metabolism". BMB Reports 45 (4): 259–64. doi:10.5483/BMBRep.2012.45.4.259. PMID 22531138.
^ Voet, D, Voet, J. G., Biochemistry (3rd Edition), John Wiley & Sons, Inc., 2004, pg 1095

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ミコフェノール酸モフェチル：リウマチ性疾患治療に使用した場合の薬理作用および
副作用 mycophenolate mofetil pharmacology and adverse effects when used in the treatment of rheumatic diseases
2. 急性移植片対宿主病の予防および治療：推奨 prevention and treatment of acute graft versus host disease recommendations
3. 代謝性ミオパチーの原因 causes of metabolic myopathies
4. 心臓移植における免疫抑制療法の導入および維持 induction and maintenance of immunosuppressive therapy in cardiac transplantation
5. 難治性皮膚筋炎のマネージメント management of refractory cutaneous dermatomyositis

English Journal

Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.

Han ZD, Zhang YQ, He HC, Dai QS, Qin GQ, Chen JH, Cai C, Fu X, Bi XC, Zhu JG, Liao DJ, Lu XP, Mo ZY, Zhu YP, Zhong WD.SourceDepartment of Urology, Guangzhou First Municipal People's Hospital, Affiliated Guangzhou Medical College, Guangzhou, 510180, China.
Medical oncology (Northwood, London, England).Med Oncol.2012 Dec;29(4):2877-88. doi: 10.1007/s12032-011-0149-9. Epub 2012 Jan 4.
The aim of this study was to identify novel serological tumor markers for human prostate cancer (PCa). We compared the gene expression profile of PCa tissues to adjacent benign tissues of prostate using gene expression microarray. 1207 genes that were consistently different from adjacent benign tiss
PMID 22215415

Virtual and experimental high-throughput screening (HTS) in search of novel inosine 5'-monophosphate dehydrogenase II (IMPDH II) inhibitors.

Dunkern T, Prabhu A, Kharkar PS, Goebel H, Rolser E, Burckhard-Boer W, Arumugam P, Makhija MT.SourceGlobal Discovery, Nycomed: A Takeda Company, Nycomed GmbH, Byk-Gulden-Str. 2, 78467, Constance, Germany.
Journal of computer-aided molecular design.J Comput Aided Mol Des.2012 Nov 2. [Epub ahead of print]
IMPDH (Inosine 5'-monophosphate dehydrogenase) catalyzes a rate-limiting step in the de novo biosynthesis of guanine nucleotides. IMPDH inhibition in sensitive cell types (e.g., lymphocytes) blocks proliferation (by blocking RNA and DNA synthesis as a result of decreased cellular levels of guanine n
PMID 23117549

Japanese Journal

Bioactive and Taste-related Compounds in Defatted Freeze-dried Chicken Soup Made from Two Different Chicken Breeds Obtained at Retail

Jayasena Dinesh D.,Jung Samooel,Alahakoon Amali U,Nam Ki Chang,Lee Jun Heon,Jo Cheorun
The Journal of Poultry Science, 2014
… DFDS made with KNC had significantly higher betaine, carnitine, inosine-5'-monophosphate, inosine, and cysteine content compared to that prepared from CB. …
NAID 130004704403

食鳥処理工程におけるブロイラーの関節損傷

長谷川剛
Nihon Chikusan Gakkaiho 85(3), 309-314, 2014
食鳥処理施設では，経済損失の重大な原因は筋肉内出血である．また，手羽折れと称される肘関節の開放性脱臼と肩関節脱臼は屠体の商品価値の低下や部分肉の整形する必要性から経営に重大な影響を及ぼす．ニワトリを処理する上でアニマルウェルフェアの啓発と経済損失の対策として，手羽折れの発生要因と防止対策をスタニング電圧，ATP関連物質から検討した．スタニング電圧をニワトリの種類ごとに設定した結果，手羽折れ発生率が …
NAID 130004700415

Optimization of Mycophenolic Acid Therapy Using Clinical Pharmacometrics

DONG Min,FUKUDA Tsuyoshi,VINKS Alexander A.
Drug Metabolism and Pharmacokinetics 29(1), 4-11, 2014
… Lastly, the potential of using a pharmacodynamic based optimal treatment strategy by focusing on MPA's target enzyme inosine monophosphate dehydrogenase (IMPDH) will be discussed. …
NAID 130004463351

Related Pictures

★リンクテーブル★

リンク元	「IMP」「inosinic acid」「イノシン一リン酸」
関連記事	「monophosphate」

「IMP」

Inosinic acid
	IUPAC name 5'-inosinic acid
	Other names IMP,; hypoxanthine ribotide
Identifiers
CAS number	131-99-7
PubChem	8582
ChemSpider	8264
MeSH	Inosine+monophosphate
ChEBI	CHEBI:17202
ChEMBL	CHEMBL1233478
Jmol-3D images	Image 1
	SMILES O=C3/N=C\Nc1c3ncn1[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)COP(=O)(O)O ;
	InChI InChI=1S/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 ; Key: GRSZFWQUAKGDAV-KQYNXXCUSA-N InChI=1/C10H13N4O8P/c15-6-4(1-21-23(18,19)20)22-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1; Key: GRSZFWQUAKGDAV-KQYNXXCUBU ;
Properties
Molecular formula	C10H13N4O8P
Molar mass	348.206 g/mol
	Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa)
	(verify) (what is: /?)
	Infobox references

　　[★]

「inosinic acid」

　　[★]

イノシン酸

関: IMP、inosinate、inosine monophosphate

「イノシン一リン酸」

　　[★]

英: inosine monophosphate IMP
関: イノシン酸

「monophosphate」

　　[★]

n.

一リン酸塩、一リン酸エステル、一リン酸

[pmid_22531138-1] Davies O, Mendes P, Smallbone K, Malys N (2012). "Characterisation of multiple substrate-specific (d)ITP/(d)XTPase and modelling of deaminated purine nucleotide metabolism". BMB Reports 45 (4): 259–64. doi:10.5483/BMBRep.2012.45.4.259. PMID 22531138.

[2] Voet, D, Voet, J. G., Biochemistry (3rd Edition), John Wiley & Sons, Inc., 2004, pg 1095

匿名

検索

案内

案内

inosine monophosphate